Literature DB >> 1772739

Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review.

S I Rapoport1.   

Abstract

PET studies of brain metabolism and blood flow in Alzheimer's disease (AD) patients lead to the following conclusions: (a) Reductions in "resting state" regional brain metabolism are roughly proportional to dementia severity. (b) These reductions are greater in association than in primary sensory and motor neocortical regions, and correlate with the distribution of neuropathology and cell loss postmortem. (c) Demented but not nondemented Down syndrome adults also have worse metabolic reductions in the association than primary neocortices, suggesting an equivalent pathological process in demented Down syndrome and AD patients. (d) Brain metabolic patterns in AD patients are heterogeneous, belonging to at least four distinct metabolic groups that correspond to different patterns of cognitive and behavioral abnormalities; the metabolic patterns have not been shown to be related to disease etiology. (e) Abnormal right-left metabolic asymmetries in mildly demented AD patients can retain their initial directions for as long as 48 months; these asymmetries precede and predict the cognitive "discrepancies" that later appear, such that moderately demented patients with disproportionate visuospatial compared with language deficits, or disproportionate visual recall compared with verbal recall, have a greater metabolic reduction in the right than left hemisphere, and vice versa. (f) Parietal association/frontal association metabolic ratios also retain their direction over time; in moderately demented patients, relative hypometabolism in the prefrontal association cortex is related to deficits in verbal fluency and attention to simple sets, whereas relative hypometabolism in the parietal association cortex correlates with failure in arithmetic, verbal comprehension, drawing, and immediate memory for visuospatial location. (g) Although metabolically spared compared with the association cortices, the primary sensory cortices, basal ganglia, thalamus, and cerebellar hemispheres show metabolic declines in AD using high-resolution PET scanners, possibly due to their connections with more pathologically affected regions. (h) Early metabolic deficits in AD are hypothesized to arise from synaptic failure in association cortical areas; such failure in the occipitotemporal visual cortex can be reversed in mildly to moderately demented AD patients who are capable of performing a face-matching task.

Entities:  

Mesh:

Year:  1991        PMID: 1772739

Source DB:  PubMed          Journal:  Cerebrovasc Brain Metab Rev        ISSN: 1040-8827


  17 in total

1.  Editorial: can we improve care for patients with dementia?

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

2.  Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses.

Authors:  A Soricelli; A Postiglione; M R Grivet-Fojaja; P P Mainenti; A Discepolo; A Varrone; M Salvatore; N A Lassen
Journal:  Eur J Nucl Med       Date:  1996-10

3.  Temporal lobe asymmetry in patients with Alzheimer's disease with delusions.

Authors:  C Geroldi; N M Akkawi; S Galluzzi; M Ubezio; G Binetti; O Zanetti; M Trabucchi; G B Frisoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

4.  Assessment of dopamine metabolism in brain of patients with dementia by means of 18F-fluorodopa and PET.

Authors:  M Itoh; K Meguro; T Fujiwara; J Hatazawa; R Iwata; K Ishiwata; T Takahashi; T Ido; H Sasaki
Journal:  Ann Nucl Med       Date:  1994-11       Impact factor: 2.668

5.  Quantitative comparison between 99mTc-HMPAO and 99mTc-ECD: measurement of arterial input and brain retention.

Authors:  A Pupi; A Castagnoli; M T De Cristofaro; L Bacciottini; A R Petti
Journal:  Eur J Nucl Med       Date:  1994-02

6.  Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.

Authors:  Winnie S Liang; Travis Dunckley; Thomas G Beach; Andrew Grover; Diego Mastroeni; Keri Ramsey; Richard J Caselli; Walter A Kukull; Daniel McKeel; John C Morris; Christine M Hulette; Donald Schmechel; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Physiol Genomics       Date:  2008-02-12       Impact factor: 3.107

7.  Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease.

Authors:  Maija Pihlajamäki; Kelly O' Keefe; Lars Bertram; Rudolph E Tanzi; Bradford C Dickerson; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jan-Mar       Impact factor: 2.703

8.  99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type--a study under clinical routine conditions.

Authors:  G Stoppe; J Staedt; A Kögler; R Schütze; H J Kunert; D Sandrock; D L Munz; D Emrich; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1995

9.  Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia.

Authors:  M Sasaki; Y Ichiya; S Hosokawa; M Otsuka; Y Kuwabara; T Fukumura; M Kato; I Goto; K Masuda
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

10.  Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism.

Authors:  I Slansky; K Herholz; U Pietrzyk; J Kessler; M Grond; R Mielke; W D Heiss
Journal:  Neuroradiology       Date:  1995-05       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.